Oncology Market Expertise and Global Contacts   I  Accredited CME for Oncologists  I   Provider Number: CPDSO 50212

Skip to navigation Skip to content
Oncology Market Expertise
Oncology Commercial Services
  • Home
  • About
  • Engage Oncologists
  • Investors & Lenders
  • Market Access & BD
  • Distributors and manufacturers
  • International Market Entry
  • In/Out-licensing DD
  • Market Intelligence
  • Advisory Boards
  • Medical Education & Training
  • Recruitment
  • News
  • Contact
  • Home
  • About
  • Engage Oncologists
  • Investors & Lenders
  • Market Access & BD
  • Distributors and manufacturers
  • International Market Entry
  • In/Out-licensing DD
  • Market Intelligence
  • Advisory Boards
  • Medical Education & Training
  • Recruitment
  • News
  • Contact
  • Home
  • About
  • Engage Oncologists
  • Investors & Lenders
  • Market Access & BD
  • Distributors and manufacturers
  • International Market Entry
  • In/Out-licensing DD
  • Market Intelligence
  • Advisory Boards
  • Medical Education & Training
  • Recruitment
  • News
  • Contact

Cancer

Cancer

Adjuvant endocrine therapy: A cornerstone of systemic therapy for hormone receptor-positive breast cancer

By AnnaH

Adjuvant endocrine therapy remains a cornerstone of systemic therapy for hormone receptor-positive breast cancer. Dr Joyce Habib explains how there has been shift in the choice and duration of adjuvant endocrine therapy in pre and postmenopausal patients.

Read More

Ovarian cancer: A patient centric approach

By AnnaH

According to World Health Organisation figures, ovarian cancer is the 18th most common cancer worldwide and the 6th most common […]

Read More

The burden of bladder cancer in the Middle East

By AnnaH

Ashraf Abdelghany, Head of Oncology at the Middle East Medical Portal provides an overview of bladder cancer in the Middle East, including causes, and incident rates. Furthermore, he discusses the importance of bladder cancer awareness in the region.

Read More

Cancer in Egypt

By AnnaH

The earliest written description of cancer is found in the Edwin Smith Papyrus that dates to Dynasties 16–17 of the […]

Read More

Are Arab Women at higher risk for lung cancer?

By AnnaH

Lung cancer is the most common cause of cancer-related death among men and women in Western countries.  Lung cancer prevalence […]

Read More

Posts pagination

  • Previous
  • 1
  • …
  • 17
  • 18
Recent Posts
  • Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor
  • Are DNA Repair Gene Alterations Associated With the Response to Platinum-Based Regimen and Immune Checkpoint Inhibitors in Patients With Solid Tumors?
  • Axicabtagene ciloleucel versus standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume
  • Daiichi Sankyo and AstraZeneca does a Batman & Robin act and fires off its second ADC shot of 2024 with another FDA BLA for Dato-DXd
  • Is it time for PET-guided therapy in follicular lymphoma?
×

Error: Contact form not found.

Back To Top

  • Home
  • Team
  • Advisory Services
  • Market Intelligence Services
  • Recruitment
  • Contact
  • Market Access / BD
  • CME Learner Resources
  • CME Evaluation Form
  • Help Centre
  • Contact
  • Disclaimers
  • Privacy & GDPR Policy
  • Website Accessibility Policy
  • Equal Opportunities Policy and Learning Charter
  • Complaints Policy
  • Contact
© Oncology Commercial Services 2025
Built with Storefront.

Copyright 2024  Oncology Commercial Services. All Rights Reserved. Fratrem Group Ltd, Company number 08002465